YP Speaker Series with Julie and Andrew Rubinstein
President of Adaptive Biotechnologies || Managing Partner at Oberland Capital

Welcome to the Gift of Life Speaker Series!
Every month, Evan Dolgow & Jared Stein will host exclusive conversations with industry titans. The events will be capped at 30-40 invite-only attendees to preserve the intimacy of this unique opportunity.
We're harnessing the momentum of the Young Professional community to support GOL's mission to double the registry to 1 million donors.
RSVP to Attend
Julie Rubinstein
President
Adaptive Biotechnologies
RSVP to Attend
Julie Rubinstein is the President of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Since 2011, she has held a variety of leadership roles and currently oversees Life Sciences Research, Clinical Diagnostics, Drug Discovery, Corporate Marketing, and Business Development functions. Julie was part of the executive team that took the company public in 2019.
Prior to joining Adaptive, Julie held various worldwide commercial development roles at Pfizer Oncology, primarily focusing on cancer immunotherapy. She also held multiple positions at Johnson & Johnson’s Ethicon Endo-Surgery division, where she helped commercialize a breast cancer diagnostic device in major European markets. She began her career in Morgan Stanley’s Global Health Care Group as a financial analyst. She currently serves on the Board of Trustees for The Valerie Fund, a pediatric oncology organization in New Jersey and New York. Julie holds a dual degree, summa cum laude, and Phi Beta Kappa, from the University of Pennsylvania’s Undergraduate Wharton School and Annenberg School of Communications, with a minor in French. She also holds an MBA from Harvard Business School.
RSVP to Attend
Andrew Rubinstein
Managing Partner
Oberland Capital
RSVP to Attend
Andrew Rubinstein is a Managing Partner at Oberland Capital. Previously, he was a Partner at Paul Capital, where he co-managed the firm's healthcare royalty platform. Prior to joining Paul Capital, he was CEO of Microban International, Ltd. a global licensing business focused on antimicrobial technologies. Mr. Rubinstein had previously worked as an investment banker in the Financial Sponsors Group at Merrill Lynch & Co. He earned a J.D. from New York University School of Law, an M.B.A. from New York University Stern School of Business, and a B.A. from the University of Pennsylvania.
Register for other sessions
Meet Your Hosts
By bridging information gaps with technology, Evan has become an early disruptor in the real estate & hospitality industries. As a machine learning (ML) consultant, Evan is passionate about democratizing ML for small businesses to equalize the playing field. He’s a 2x bone marrow donor with Gift of Life & lives by the motto “if you make the stage grand, guests will assume their roles.”
Jared is an innovative technology leader who is always evolving digital experiences. Through spearheading initiatives at rapid-growth startups and charitable foundations, Jared sets a high bar for leadership. He’s a bone marrow donor with Gift of Life & has added 3,000+ volunteer donors to the bone marrow registry.